Premium Stories: Exclusive Content from VCCircle
Finance
Former KPMG exec floats valuation advisory firm, to go on hiring spree
A former KPMG executive, who co-founded a boutique advisory firm last year, has floated another firm that will offer valuation...
Finance
Centrum mulls bumping up unsecured lending portfolio with personal loans
Centrum is considering expanding its unsecured lending portfolio, currently consisting of microfinance, by launching personal...
Manufacturing
After selling ATG for over $1 bn, Mahansaria dials old PE backer for new tyre venture
Yogesh Mahansaria, who along with his father Ashok exited Balkrishna Industries Ltd to create Alliance Tire Group (ATG)...
Finance
Lightbox's Sandeep Murthy on why the VC firm will keep making concentrated bets
In an industry where most venture capital firms tend to spread their investments for the fear of missing out, Lightbox ......
Infrastructure
GIC tastes another lemon as it exits shipping firm with big haircut
Singapore sovereign wealth fund GIC Pte Ltd, one of the most active foreign investment firms in India, has exited a ......
Finance
How much money did PE investors make by selling Enamor stake to Advent?
Private equity firms India Alternatives and Faering Capital booked an exit from Enamor earlier this month after the lingerie maker ......
Consumer
How Madhu Jayanti plans to expand tea business after buying Eveready brands
Madhu Jayanti International Pvt. Ltd aims to double the revenue from the tea brands it bought from Eveready Industries India ......
Finance
Quadria Capital, ING team up to offer loans linked to ESG targets
Healthcare-focussed private equity firm Quadria Capital has secured a commitment from Dutch financial services giant ING Group...
Healthcare
Diagnostics firms shouldn't fear price controls: Panellists at VCCircle summit
Diagnostics companies must focus on providing good-quality services and building sustainable business models instead of worrying...
Healthcare
Pharma profit pools likely to shift from pills to services: Cipla CEO
Profit pools will likely slink away from manufacturing to care as pharmaceutical firms re-imagine themselves as services providers...
